Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract
Clinical trial NCT04633187 · TERMINATED
Trial details
- NCT number
- NCT04633187
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2023-05-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.